ALK and neoplasm: Although the STAT3 signaling pathway has been reported to regulate PD-L1 expression in the NPM/ALK-carrying T cell lymphoma (ALK + TCL) cells [20], BM cell interaction did not activate STAT3 in B16F10 tumor cells.